OPM Director Scott Kupor discloses sales of Erasca (ERAS) and Revolution Medicines (RVMD)
- Filer
- Scott A Kupor
- Transactions
- 2 across 2 companies
- Direction
- 0 bought · 2 sold
- Notification date
- 2026-09-30T04:19:39
All 2 transactions in this filing
Scott Aaron Kupor, Director of the Office of Personnel Management, disclosed two transactions on an OGE Form 278-T Periodic Transaction Report signed on July 31, 2026.
Both transactions took place on July 30, 2026, and represent sales of common stock. Specifically, the filer disposed of shares in Erasca Inc. (ERAS) valued between $1,001 and $15,000, and shares in Revolution Medicines Inc. (RVMD) also valued between $1,001 and $15,000.
Combined, the total value of the disclosed transactions falls in the range of $2,002 to $30,000, representing modest transaction amounts under federal reporting thresholds.
Important Disclaimer
Amounts are disclosed by law as broad ranges, not exact figures - this reflects the range as filed, not a precise dollar amount. This content is summarized from a public government disclosure filing and may contain errors.
The Filing Fool is not a registered investment adviser. Nothing here is a recommendation or solicitation to buy, sell, or hold any security, nor any claim about a filer's intent or knowledge.
